These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 221745)

  • 1. Comparison of the urinary excretion of free aldosterone and its acid-labile conjugate in rats during experimental hyperaldosteronism.
    Guelpa-Decorzant C; Riondel AM; Chabert PR; Vallotton MB
    J Steroid Biochem; 1979 Apr; 10(4):365-9. PubMed ID: 221745
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: On the role of diuretic-and spironolactone-induced hyperaldosteronism on electrolyte excretion in man.
    Erbler H
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R19. PubMed ID: 4276539
    [No Abstract]   [Full Text] [Related]  

  • 3. Temporal relationship between hyperaldosteronism, sodium retention and ascites formation in rats with experimental cirrhosis.
    Jiménez W; Martinez-Pardo A; Arroyo V; Bruix J; Rimola A; Gaya J; Rivera F; Rodés J
    Hepatology; 1985; 5(2):245-50. PubMed ID: 3979957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of the spironolactone test in the diagnosis of primary hyperaldosteronism.
    Jessurun RF; Struyvenberg A; Dorhout Mees EJ
    Neth J Med; 1979; 22(1):23-6. PubMed ID: 418941
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of acute potassium loading on plasma renin and on urinary aldosterone in rats.
    Corvol P; Oblin ME; Degoulet P; Fressinaud P; Menard J
    Endocrinology; 1977 Apr; 100(4):1008-13. PubMed ID: 837868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acid labile aldosteronuria. Comparison of radio-immunoassay and colorimetry (author's transl)].
    de Talancé N; Boulangé M
    Ann Biol Clin (Paris); 1980; 38(5):309-13. PubMed ID: 7469148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An observation of Conn's syndrome. Clinical and biological study].
    Tourniaire J; Revol A; Maret G; Blanc-Brunat N
    Rev Fr Endocrinol Clin; 1968; 9(4):333-50. PubMed ID: 4302797
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of saluretics and spironolactone on aldosterone production and electrolyte excretion in man.
    Erbler HC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 286(2):145-56. PubMed ID: 4281879
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of aldosterone production in diuretic-induced hyperaldosteronism by aldosterone antagonist canrenone in man.
    Erbler HC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(4):395-401. PubMed ID: 4280522
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of corticotropin on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
    Newton MA; Laragh JH
    J Clin Endocrinol Metab; 1968 Jul; 28(7):1006-13. PubMed ID: 4298942
    [No Abstract]   [Full Text] [Related]  

  • 11. A direct radioimmunoassay for free aldosterone in urine without extraction and chromatography.
    Hubl W; Stahl F; Büchner M; Garten CD
    Endokrinologie; 1976; 68(3):283-7. PubMed ID: 1009907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bartter's syndrome with normal urinary excretion of prostaglandin E: therapeutic effects of propranolol, spironolactone, indomethacin and potassium chloride.
    Sato M; Abe K; Yasujima M; Otsuka Y; Chiba S; Haruyama T; Yoshinaga K; Saito T; Kabuki J
    Tohoku J Exp Med; 1980 Jun; 131(2):151-9. PubMed ID: 7404582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of essential arterial hypertension with spironolactone: its value in the detection of primary hyperaldosteronism and prediction of its efficacy].
    Fournier A; Nakache JP; Salmon D; Kazandjian M; Baulon A; Legrand JC; Menard J; Lagrue G
    J Urol Nephrol (Paris); 1972 Dec; 78(12):1023-7. PubMed ID: 4661188
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary tetrahydroaldosterone and aldosterone-18-glucuronide excretion in white and black normal subjects and hypertensive patients.
    Gomez-Sanchez CE; Holland OB
    J Clin Endocrinol Metab; 1981 Feb; 52(2):214-9. PubMed ID: 7462387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aldosterone excretion and plasma renin activity in patients with essential hypertension and with primary aldosteronism (author's transl)].
    Helber A; Meurer KA; Rosskamp E; Wambach G; Dickmans HA; Kaufmann W
    Klin Wochenschr; 1974 Oct; 52(20):966-73. PubMed ID: 4444216
    [No Abstract]   [Full Text] [Related]  

  • 16. 21-Deoxytetrahydroaldosterone excretion in primary hyperaldosteronism.
    Abdelhamid S; Lewicka S; Vecsei P; Winter J
    Cardiology; 1985; 72 Suppl 1():102-6. PubMed ID: 4053120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of spironolactone on electrolytes, renin, ACTH and corticosteroids in the rat.
    Chabert PR; Guelpa-Decorzant C; Riondel AM; Vallotton MB
    J Steroid Biochem; 1984 Jun; 20(6A):1253-9. PubMed ID: 6087026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary free aldosterone in healthy people and in patients with primary aldosteronism.
    Deck KA; Champion PK; Conn JW
    J Clin Endocrinol Metab; 1973 Apr; 36(4):756-60. PubMed ID: 4686382
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of glucocorticoid administration on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
    Newton MA; Laragh JH
    J Clin Endocrinol Metab; 1968 Jul; 28(7):1014-22. PubMed ID: 4298943
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hyperaldosteronism and the use of aldactone in cardiac insufficiency].
    Korochkin IM; Matveeva IV; Sidorenko BA; Arshakuni RO
    Kardiologiia; 1968 Dec; 8(12):74-81. PubMed ID: 5736746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.